| Wal-mart Pharmacy 10-4100 | |
| 2255 N University Pkwy, Provo, Utah 84604 | |
| (385) 219-3077 |
| Name | Wal-mart Pharmacy 10-4100 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 2255 N University Pkwy, Provo, Utah 84604 |
| Type | Pharmacy |
| Phone | (385) 219-3077 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers at Mount Sinai School of Medicine have found that the majority of physicians and members of the American Medical Association (AMA) opposed the AMA's position on coverage expansions-the most contentious issue in the recent health care reform debate. The data are published in a letter in the June 9th issue of the New England Journal of Medicine.
A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).
The U.S. Department of Veterans Affairs (VA) has awarded QuadraMed® Corporation, a leading provider of healthcare technologies and services, a five-year, $211 million contract to implement its Quantim® Coding, Compliance and Abstracting solution. The comprehensive, integrated solution will improve the VA healthcare system's coding productivity and accuracy through real-time compliance monitoring and customizable billing processes.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
› Verified 2 days ago
| NPI Number | 1427658046 |
| Type | Pharmacy |
| Address | 2255 N University Pkwy, Provo, UT 84604 |
| Phone Number | 385-219-3077 |
News Archive
Researchers at Mount Sinai School of Medicine have found that the majority of physicians and members of the American Medical Association (AMA) opposed the AMA's position on coverage expansions-the most contentious issue in the recent health care reform debate. The data are published in a letter in the June 9th issue of the New England Journal of Medicine.
A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).
The U.S. Department of Veterans Affairs (VA) has awarded QuadraMed® Corporation, a leading provider of healthcare technologies and services, a five-year, $211 million contract to implement its Quantim® Coding, Compliance and Abstracting solution. The comprehensive, integrated solution will improve the VA healthcare system's coding productivity and accuracy through real-time compliance monitoring and customizable billing processes.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
› Verified 2 days ago
| NPI Number | 1447674569 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-4100 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2255 N University Pkwy, Provo, UT 84604 |
| Phone Number | 801-377-2270 |
News Archive
Researchers at Mount Sinai School of Medicine have found that the majority of physicians and members of the American Medical Association (AMA) opposed the AMA's position on coverage expansions-the most contentious issue in the recent health care reform debate. The data are published in a letter in the June 9th issue of the New England Journal of Medicine.
A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).
The U.S. Department of Veterans Affairs (VA) has awarded QuadraMed® Corporation, a leading provider of healthcare technologies and services, a five-year, $211 million contract to implement its Quantim® Coding, Compliance and Abstracting solution. The comprehensive, integrated solution will improve the VA healthcare system's coding productivity and accuracy through real-time compliance monitoring and customizable billing processes.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
› Verified 2 days ago
News Archive
Researchers at Mount Sinai School of Medicine have found that the majority of physicians and members of the American Medical Association (AMA) opposed the AMA's position on coverage expansions-the most contentious issue in the recent health care reform debate. The data are published in a letter in the June 9th issue of the New England Journal of Medicine.
A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).
The U.S. Department of Veterans Affairs (VA) has awarded QuadraMed® Corporation, a leading provider of healthcare technologies and services, a five-year, $211 million contract to implement its Quantim® Coding, Compliance and Abstracting solution. The comprehensive, integrated solution will improve the VA healthcare system's coding productivity and accuracy through real-time compliance monitoring and customizable billing processes.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
› Verified 2 days ago
Alpine Home Medical Equipment Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 1481 N State St, Provo, Utah 84604 Phone: (801) 852-0077 | |
Excel Optical Type: Eyewear Supplier (Equipment, not the service) Location: 1735 N State St, Provo, Utah 84604 Phone: (801) 374-1818 | |
Intermountain Homecare Type: Medicare Supplier Location: 289w 1230 N, Provo, Utah 84604 Phone: (801) 357-8250 | |
Northwest Orthoticsprosthetics Inc Type: DME Supplier - Customized Equipment Location: 1675 N Freedom Blvd, Provo, Utah 84604 Phone: (801) 377-3433 | |